how glp-1 drugs cause gastroparesis lawsuits medication side effects for diabetes and weight loss Ozempic Lawsuit for Blindness, Stomach

Retatrutide (Eli Lilly), a triagonist currently in phase III clinical trials (TRIUMPH-1 NCT05929066 and others 3 ) adds a glucagon receptor agonist to its mechanism of action, promising an even greater impact on weight loss

Unlike artificial sweeteners, which often just replace sugar, allulose actively improves carbohydrate metabolism , making it potentially useful for those with insulin resistance or prediabetes

doi: 10.1186/s13098-025-01903-5, 27

So, GLP-1 receptor agonists significantly reduce blood sugar levels and are an effective treatment for type 2 diabetesparticularly the longer-lasting and recent versions of GLP-1s, semaglutide and tirzepatide

Similarly, GLP-1/CCK fusions can capitalize on non-redundant food intake mechanisms to lower body weight

The first demonstration that DPP-4 inhibition reduces blood glucose levels in type 2 diabetes was published in 2002 [36]